Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intel Corp (INTC) vs Tempus AI (TEM) Price & Performance

Intel CorpTrade
Tempus AITrade

Price performance (Past 24H)

Key statistics

Intel Corp vs Tempus AI — how do they compare? Intel Corp trades at $104.3 (market cap $487.82B), while Tempus AI trades at $49.54 (market cap $8.69B). The key difference: Intel Corp is far larger — about 56.1× Tempus AI's market cap, and Intel Corp pays a 2.24% dividend while Tempus AI pays none. Which is the better fit depends on your goals.

INTCTEM
Market Cap
$487.82B$8.69B
Volume
43,552,012
Sector
TechnologyBroad Market / Factor
52-Week High
$140.94$103.25
52-Week Low
$19.31$42.37
Enterprise Value
$500.07B$9.37B
Dividend Yield
2.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intel Corp

Intel (INTC) trades at $97.87, up 2.97% on the day, with technical indicators showing a bullish overall signal despite mixed moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$267 million in 2025. Recent news highlights volatility in semiconductor stocks amid AI-driven market shifts, with Intel expanding its Google Cloud AI partnership to boost enterprise growth.

Intel's outlook is cautiously optimistic, supported by earnings beats and strategic AI initiatives, but risks include intense competition, margin pressures, and sector volatility. The consensus price target of $109.55 suggests potential upside, though investors must weigh financial recovery against technological challenges in a dynamic chip market.

Tempus AI

Tempus AI (TEM) trades at $48.41, down 7.74% in the last 24 hours, reflecting a bearish technical signal. The company reported revenue of $1.27 billion in 2025 but a net loss of $245.03 million, with negative profitability metrics. Recent news highlights growth in AI-driven diagnostics and data services, including FDA approvals and research collaborations. The stock is trading well below the analyst consensus price target of $68.50, with a majority of analysts maintaining a Buy rating.

The outlook for TEM is a mix of high growth potential in healthcare AI and significant financial risk due to persistent losses. Investment opportunity lies in its proprietary data platform and expanding market reach, but risks include execution challenges and cash burn. Wall Street sentiment remains positive on long-term prospects, but investors should weigh the volatility against the company's unproven path to profitability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Intel Corp

Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.

Read more on INTC

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM